Clinical Trial Update: Salivary Transcriptome Biomarkers for Early Diabetes Detection

View source ↗

Summary

A clinical trial update describes salivary transcriptome biomarkers being evaluated for early detection of diabetes, including pre-diabetes and type 2 diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: PeriRx | Conditions: Pre-diabetes, Type II Diabetes | Status: UNKNOWN